Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details

This article is part of the supplement: 11th International Symposium on the Cells of the Hepatic Sinusoid and their Relation to Other Cells

Open AccessProceedings

Thioredoxin prevents thioacetamide-induced acute hepatitis

Hiroaki Okuyama1 email, Yasuyuki Shimahara1 email, Hajime Nakamura2 email, Shinichi Araya2 email, Norifumi Kawada3 email, Yoshio Yamaoka3 email and Junji Yodoi2 email

1Department of Gastroenterological Surgery, Graduate School of Medicine, Kyoto University, Japan

2Department of Biological Responses, Laboratory of Infection and Prevention, Institute for Virus Research, Kyoto University; Shogoin, Kawahara-cho, Sakyo-ku, Kyoto, Japan 606-8397

3Department of Hepatology, Graduate School of Medicine, Osaka City University, Japan

author email corresponding author email

Comparative Hepatology 2004, 3(Suppl 1):S6doi:10.1186/1476-5926-2-S1-S6

Published: 14 January 2004

First paragraph (this article has no abstract)

Thioredoxin (Trx) is an endogenous multifunctional protein with a redox-active disulfide/dithiol within the conserved active site sequence: -Cys-Gly-Pro-Cys- [1]. Trx is also a stress-inducible protein whose expression is enhanced by various types of stresses, e.g., viral infection, exposure to UV light, x-ray irradiation, and hydrogen peroxide (H2O2) [2]. Furthermore, Trx is a scavenger of reactive oxygen species (ROS), and recombinant Trx has protective activity against ROS-mediated cytotoxicity [3]. We have previously reported that Trx attenuates an ischemic brain damage by scavenging radicals [4].


© 1999-2008 BioMed Central Ltd unless otherwise stated < info@biomedcentral.com >   Terms and conditions